Heimdall Insights

Global Next-Generation Tissue Biomarkers Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Next-Generation Tissue Biomarkers Market was valued at $3.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 12.7% CAGR, to an estimated market size of $5.5 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Next-Generation Tissue Biomarkers market encompasses advanced diagnostic tools, technologies, and assays – specifically Next-Generation Sequencing (NGS), genomic-based assays, and digital pathology – used to identify and analyze biological markers within tissue samples. This market excludes traditional blood-based liquid biopsies unless used in conjunction with tissue analysis, focusing instead on personalized medicine and precision oncology through the study of genetic, proteomic, and transcriptomic indicators in solid tissues.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Next-Generation Tissue Biomarkers Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Next-Generation Sequencing (NGS)
  • Immunohistochemistry (IHC) & PCR
  • Digital Pathology & AI
  • Other (Proteomics & Mass Spectrometry)